Specialty pharmaceutical company Opiant Pharmaceuticals Inc. appointed Richard Daly as a nonexecutive director, pushing the number of board members to six.
Daly is currently chairman and CEO of Neuralstem Inc. and also serves on the board of Catalyst Pharmaceuticals Inc.
